ASCERTAIN addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies in Europe.

ASCERTAIN

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Euro

Apple Mobile Web Clips Icon

HSTS

Content Delivery Network

Amazon

LetsEncrypt

Lead Product Manager

Eli Bernstein

Head of Product

Geoff Brockenshire

Head of Product - Ascertain

Chief Executive Officer

Mark Michalski

Founder and Chief Executive Officer

John Beadle

Founding Investor and Board Member

Artificial Intelligence (AI) Companies With More Than 10 Employees (Top 10K)

East Coast Companies With Fewer Than 100 Employees (Top 10K)

Artificial Intelligence (AI) Companies With Fewer Than 1000 Employees (Top 10K)

Greater New York Area Companies (Top 10K)

Ascertain is a revolutionary new partnership between Northwell Health, New York’s largest healthcare provider, and Aegis Ventures, a dynamic startup studio. This unique partnership assembles leading medical, technology, and business resources to create a first-of-its-kind company creation platform for healthcare innovation to address healthcare’s most challenging quality, equity, and cost problems. Ascertain creates companies that improve quality of care, patient experience, and long-standing health, placing patient needs at the center of every business model, technology solution, and product.

Venture Round - Ascertain

Computer and Software Services and Scientific Services

New York

United States

North America

Ascertain

Mark Michalski, CEO of Ascertain on AI in health care, seizing opportunity (podcast) - Boston Business Journal

Ascertain Announces Leadership Team With Appointment of ...

Ascertain's predictive AI preeclampsia algorithm marks continued focus on femtech amid cooling markets

North American Startup Funding Fell Further In Q2

India

Asia

ASCERTAIN addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies in Europe. The project aims to create a tool for decision-makers to understand the cost and value of these technologies.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 18, 2024 2:50 PM	c62e3446
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 2:50 PM	574e344a
crunchbase trigger	general	Nov 18, 2024 2:50 PM	9e3eed6d
crunchbase profile	general	Nov 19, 2024 2:55 AM	afab5356
li profile	general	Nov 18, 2024 2:50 PM	59abfa5f
translate crunchbase fundingrounds	general	Nov 19, 2024 3:15 AM	287f3e39
peers	general	Nov 18, 2024 2:50 PM	05bba050
news basic	general	Nov 18, 2024 2:50 PM	8ed1e157
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ACCE

EU:ACCESS2MEDS

ASCERTAIN